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ABSTRACT 
 
ELECTROSTATIC EFFECTS ON THE SELF-ASSEMBLY 
MECHANISM OF PEPTIDE AMPHIPHILES 
 
Sıla Toksöz 
M.S. in Materials Science and Nanotechnology 
Thesis Advisor: Assist. Prof. Dr. Mustafa O. Guler 
July 2010 
Self-assembling peptide amphiphiles, synthesized through solid phase peptide 
synthesis – a bottom-up approach, have been used with various tissue 
engineering purposes. Peptide amphiphile molecules self-assemble into 
nanofibers, which form three dimensional networks mimicking the extracellular 
matrix. Electrostatic interactions affect the formation of nanofibers. The effect 
of charged groups  on the peptides on nanofiber formation were studied in this 
work. Neutralization of the charged groups by pH change, electrolyte addition or 
addition of oppositely charged biomacromolecules triggered the aggregation of 
the peptides. To understand the controlled formation of the gels composed of 
peptide nanofibers better can help the researchers develop bioactive collagen 
mimetic nanofibers for tissue engineering studies and use them in angiogenesis. 
Results obtained by Fourier Transform Infrared Spectroscopy (FT-IR), Circular 
Dichroism (CD), Rheology, pH titration, Atomic Force Microscopy (AFM), 
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Scanning Electron Microscopy (SEM) and Transmission Electron Microscopy 
(TEM); as well as the potential of using the peptide amphiphile molecules to 
promote angiogenesis, are described.  
Keywords: Self-Assembly, Nanofiber, Peptide, Gel, Peptide Amphiphile, 
Angiogenesis 
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ÖZET 
 
 
PEPTĠT AMFĠFĠLLERĠN KENDĠLĠĞĠNDEN 
DÜZENLENMESĠNDE ELEKTROSTATĠK ETKĠLEġĠMLERĠN 
ETKĠLERĠ  
 
 
Sıla Toksöz 
Malzeme Bilimi ve Nanoteknoloji Programı, Yüksek Lisans 
Tez Yöneticisi: Yard. Doç. Dr. Mustafa Özgür Güler 
Temmuz 2010 
 
Katı hal peptit sentezi yöntemi ile üretilmiĢ kendiliğinden düzenlenen peptit 
amfifiller, doku mühendisliği çalıĢmaları için kullanılmaktadır. Peptit amfifil 
molekülleri nanofiber olarak düzenlenir, bu nanofiberler de ekstraselüler matriks 
benzeri üç boyutlu ağlar oluĢtururlar. Elektrostatik etkileĢimler nanofiber 
oluĢumu üzerinde etkilidirler. Peptit üzerindeki yüklerin nanofiber 
oluĢumundaki etkileri bu araĢtırmada çalıĢılmıĢtır. pH değiĢikliği, ya da zır 
yüklü elektrolit ve biyomakromoleküllerin eklenmesiyle, yüklü grupların 
nötralizasyonu ve peptit agregasyonunu sağlanmıĢtır. Peptit nanofiber jellerinin 
kontrollü oluĢumunu anlamak, kolajen benzeri biyoaktif yapılar üretilip bunların 
doku mühendisliği ve anjiyojenez çalıĢmalarında kullanılmalarını mümkün 
vi 
 
kılacaktır. Fourier Transform Kızılötesi Spektroskopisi (FT-IR), Circular 
Dichroism (CD), Reoloji, pH titrasyonu, Atomik Kuvvet Mikroskopu (AFM), 
Taramalı Elektron Mikroskopu (SEM), Geçirmeli Elektron Mikroskopu (TEM) 
sonuçları ve peptit amfifil moleküllerinin anjiyojenez amaçlı kullanım 
olasılıkları anlatılmaktadır. 
Anahtar Kelimeler: Kendiliğinden düzenlenme, Nanofiber, Peptit, Jel, Peptit 
amfifil, Anjiyojenez 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1  Introduction 
With the increasing life span thanks to the advances in the medical field, 
the incidence of age-related illnesses has largely increased in the late 20th 
and early 21st centuries. The organs and tissues, after serving for a specific 
time, do fail. Genetics and environmental effects have a role in this process 
but the main causes are still unknown. To change the non-functional parts of 
the body with functional ones in large scale has been the dream of humanity, 
and we are close to it than ever. However, the number of people who need 
transplants is far greater than available organs and tissues. Therefore, some 
other methods to fill the gap between patients and available transplants have 
been proposed, such as producing organs in laboratory or making the body 
cure itself by the aid of synthetic and natural materials. Tissue engineering 
allows scientists to produce scaffolds from synthetic or natural materials and 
use them for the growth and differentiation of the cells into desired tissues. 
Complex biological processes like development, immune response, 
wound healing are controlled by the adhesion of cells to extracellular matrix 
proteins, effecting through dynamic and specific regulation of cellular 
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behavior1. To have control over cell attachment, proliferation and 
differentiation, scaffolds used in tissue engineering should mimic the 
extracellular matrix. Extracellular matrix, which consists of proteins and 
proteoglycans, is an elastic network surrounding and supporting cells, as 
well as providing adhesion sites for cells. A widely mimicked component of 
the matrix is collagen2. Collagen has been employed in various applications 
ranging from biocompatible coatings3 to tissue engineering4 and drug 
delivery5. It serves as a structural and organizational framework for many 
types of tissues including cartilage, bone, tendon, blood vessels, skin, and 
fascia; collagen is the main structural part of the connective tissue6. It 
promotes adhesion of cells and mediates intracellular signals critical to 
tissue functioning7-8. There are many natural and synthetic polymers which 
are used as biomaterials; however, the characteristics of collagen as a 
biomaterial are different compared to those polymers, mainly in its mode of 
interaction in the body9. Collagen has a better biocompatibility and 
biodegradability rate, and a lower antigenicity10 compared to other polymers 
such as albumin and gelatin. The health concerns related to the source of 
natural collagen, and the desire to enhance the biological functions of 
collagen, have resulted in studies where the researchers try to generate 
scaffolds and biomaterials mimicking natural collagen11-12.    
When wounds have formed as a result of surgical application of 
biomaterials as tissue replacement or some other reason, angiogenesis might 
contribute in faster healing. Wound healing is a very complex process of  
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 different stages, one stage being angiogenesis. 
Scaffolds based on collagen mimicking materials are promising 
candidates to promote angiogenesis
13-14
. Vascular endothelial growth factor 
(VEGF) plays a central role in the angiogenesis process associated with 
cancer. Endothelial cell migration and proliferation are usually observed in 
the extracellular matrix during this process. VEGF and its mimicks have 
been used as inducers of angiogenesis in numerous studies
15-17
, and VEGF 
antagonists have been shown to inhibit angiogenesis
18-19
.  
Heparin and heparan sulfate belong to heparin/heparan sulfate-like  
glycosaminoglycans (HSGAGs), which are known to interact with VEGF in 
the angiogenesis process. The sulfate and acetyl groups are known to 
participate in the binding; however, electrostatic interactions might also 
contribute to interactions, as in the case of  IdoA residues of heparin and 
heparan sulfate
20
.  
Designing structures, which bear sulfate groups and are able to take part 
in electrostatic interactions, will aid researchers develop heparin-mimicking 
structures to be used as angiogenesis promoters by bringing the target 
proteins already found in the tissue to local sites, which is advantageous over 
the direct use of proteins by means of price and availability. 
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1.2  Self-Assembly Mechanism 
In “top-down” approaches, bulk materials are processed to form 
nanostructures. Lithography, a top-down approach, can be used to produce 
patterns to promote cell growth; etching techniques can be employed to 
roughen metallic implants. These methods have some limitations in the 
processing of the starting materials and in the size of features.  
Bottom-up approaches, on the other hand, offer many features of 
different sizes and shapes. Self-assembly, an example of bottom-up 
methods, is the ordering of small molecules into larger molecules through 
non-covalent interactions. Theoretical understanding of the self-assembly 
principles in living organisms has contributed to the opportunities self-
assembling materials offer for the design of new materials, in fields such as 
regenerative medicine
21-23
, electronics
24-26
 and optics
27
. 
Examples of self-assembly can be observed in nature, where complex 
structures such as folded proteins, double helices of DNA and lipid 
membranes form without chemical reactions. The non-covalent forces acting 
in the self-assembly are hydrogen bonding, hydrophobic effects, electrostatic 
effects, and van der Waals forces that are employed by nature to form 
biological objects in nanoscale constituting from as few as two molecules to 
thousands of molecules. These interactions are very dynamic and usually 
delicate because of their relatively weak nature, the strength of the forces 
varies from less than 5 kJ mol
−1
 for van der Waals interactions to up to 
120 kJ mol
−1
 for hydrogen bonding, much less than the covalent bonds 
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which can have energies up to 400 kJ mol
−1 28
.  Nevertheless, a number of 
these weak interactions are strong enough to hold the molecules together and 
yield a stable assembly. Interactions between molecules and cells, to name a 
few ligand-receptor, cell-surface, and protein-protein interactions, occur in 
nanoscale and it is this ability and knowledge the tissue engineers would like 
to acquire and simulate in laboratory.  
Type of Interaction Strength (kJ/mol) 
Electrostatic 50-300 
Coordination binding 50-200 
Hydrogen Bonding 5-120 
π-π Stacking 0-50 
Solvophobic Depends on solvent 
type 
van der Waals < 5 
Covalent 350 
Table 1. Strength of non-covalent interactions 
 
So far, the use of a broad range of nanostructures including peptide 
nanofibers
29
, carbon nanotubes
30-31
, inorganic nanoparticles
32
, and 
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dendrimers
33-34
 in areas like disease diagnostics, drug delivery and 
regenerative therapy has been investigated.  
Peptides provide a unique and tailorable platform for designing self-
assembling nanostructures. The selection of the amino acids determines the 
final secondary, tertiary and quaternary structures through folding and 
hydrogen bonding. Peptides are also attractive due to their biocompatibility 
and biodegradability.  
The synthesis of peptides had been done by solution-phase synthesis for 
a long time. With the invention of solid phase peptide synthesis (SPPS), the 
use of solution-phase synthesis diminished, although it is still used for large-
scale industrial production of peptides. For incorporation of unnatural amino 
acids into the sequence, modification of the peptide backbone, synthesis of 
D-peptides, and synthesis of the peptides which are difficult to express in 
bacteria, solid phase peptide synthesis method is widely employed. 
  
1.3 Solid Phase Peptide Synthesis 
R. B. Merrifield, nearly a half century ago, proposed the so-called “Solid 
Phase Peptide Synthesis” method to prepare a tetrapeptide via one-by-one 
addition of benzyloxycarbonyl amino acids to a polystyrene resin
35
. He also 
synthesized amino acids protected with t-butoxycarbonyl groups. This 
method is inexpensive, rapid and simple. With time, the method has been 
improved by using different types of solvents, reagents and protecting 
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groups. 9-fluorenylmethoxycarbonyl (Fmoc) is one of the protecting groups, 
and it has been employed in this study to protect the N-terminus.  
First, the insoluble resin is deprotected from the Fmoc group, which is 
base-labile, usually piperidine is used for this purpose. Afterwards, the first 
amino acid is attached to the resin. Deprotecting the Fmoc group from the 
first amino acid, the second amino acid is added and this procedure repeats 
until a desired number of amino acids is obtained. After each coupling, the 
resin is washed with acetic anhydride to get rid of excess reagents and 
improve the purity. In the final step, the peptide is deprotected and TFA 
cleavage is done to detach the peptide from the support resin. 
The peptides in this study have been constructed from enantiomerically 
pure amino acids with differing chirality via solid phase synthetis technique. 
Constructing peptides on an insoluble solid support has made the separation 
of the peptide from soluble reagents and the removal of excess reagents 
easier, minimized material loss and maximized yield.  
The polymerization approach has been used widely, however it has some 
disadvantages such as lacking control over the molecular weight of the ﬁnal 
product and sequence diversity. The development of solid phase synthesis 
contributed to the production of collagen mimetic materials. Peptides having 
differing chain lengths and sequences can be synthesized by this synthesis 
method.  
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Figure 1. Solid Phase Synthesis Diagram. Reproduced with permission from Sigma-
Aldrich. 
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1.4 Effects of Electrostatic Interactions on Self-assembly 
of Peptide Amphiphiles 
Peptides present a unique platform for self-assembling nanostructures. β-
sheet forming ones attract particularly interest by their ability to use 
hydrogen bonding to form one-dimensional nanostructures
36
.  
Peptide amphiphile molecules are an example of peptides, which through 
β-sheet formation, self-assemble into fibrillar structures and form self-
supporting three dimensional networks which can mimic the extracellular 
matrix. The conical shape of the molecule is suggested to contribute to the 
formation of a fibrillar structure instead of a micellar one. Hydrophilic 
peptide portion of the molecule presents itself on the outside of the fiber in 
water, hydrophobic carbon tail position ns inside the fiber; forming 
nanofibers around 8-10 nm in diameter and up to a few micrometers in 
length. (Figure) The driving force is based on intermolecular hydrogen 
bonding and hydrophobic collapse of the alkyl tail. In physiological media, 
charged groups in the sequence become neutralized by electrolytes, so the 
electrostatic repulsion decreases; then, the hydrophobic collapse makes the 
alkyl tails aggregate to protect themselves from the aqueous environment, 
and parallel to the long axis of the fibers, hydrogen bonding occurs
37
. 
During the design of the peptides, biological signaling sequences can be 
incorporated in the sequence to obtain biological activity. Another way of 
10 
 
obtaining biological activity can be achieved though pH- and salt-responsive 
design. 
pH- and salt-responsive design ability enables the use of the peptide 
amphiphile molecules in minimally invasive therapies, where encountering 
electrolytes and biomolecules such as lipids, carbohydrates and nucleic acids 
in the tissue can induce self-assembly of the nanofibers and formation of 
three dimensional networks which contain preferred loads. This strategy is 
useful for functionally mimicking biomacromolecules.  
Interactions between headgroups have been computationally simulated to 
show that electrostatic interactions prevail the hydrophobic interactions 
between alkyl tails and determine the final cylindrical structure
38
. As 
opposed to electrostatic interactions in conventional micelles, the 
interactions are attractive between hydrophilic groups of peptide 
amphiphiles. In the same study, the effects of low and high pH have also 
been studied.  
Understanding the effects of electrostatic interactions on the self-assembly of 
peptide amphiphiles will help us to generate more efficient networks and scaffolds 
for a variety of applications. In this study, we aim to see the electrostatic and 
charge screening effects on peptide amphiphile self-assembly 
experimentally, which is induced by salt ions, macromolecules and pH 
change.  
 
11 
 
1.5 Peptide Amphiphiles for Angiogenesis 
Wound healing comprises several overlapping phases, which involve 
different cells and growth factors. The first phase, named as inflammatory 
phase, includes haemostasis and inflammation
39
. Haemostasis is maintained 
by vasoconstriction, platelet plug formation, and blood coagulation. 
Vasoconstriction occurs immediately after the injury to prevent blood loss. 
Fibrin clot, which serves as a shield against bacteria and a scaffold for 
infiltrating cells until the healing occurs, is formed afterwards. Formation of 
fibrin clot is induced by mediators such as prostaglandins and thromboxanes 
released from ruptured cell membranes
40
. At the same time, platelets come 
to the wound and form platelet plugs, again to prevent blood loss
39
. Platelets 
release several chemotactic molecules and growth factors attracting the 
circulating immune cells such as neutrophils and macrophages to the wound. 
Neutrophils eliminate foreign bodies, dead tissue and damaged ECM by 
phagocytosis and release of proteases
41
. After 2 days, blood and tissue 
monocytes differentiate into wound macrophages. Macrophages take part in 
the removal of bacteria, bacteria-containing neutrophils, damaged cells and 
matrix. They also release growth factors that induce fibroplasia and 
angiogenesis. Macrophage appearance at the wound site indicates the end of 
the inflammatory phase and the start of the proliferative phase. During this 
phase, re-epitheliazation occurs by migration of the keratinocytes from the 
dermal layer.  
Angiogenesis, formation of new blood vessels, is another important step 
for the formation of new tissues. VEGF-A and FGF-2 induce angiogenesis
39
. 
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Fibroblasts migrate from wound edges and some of them differentiate into 
myofibroblasts. Myofibroblasts are contractile, so bring the edges of the 
wound together to minimize the required amount of the matrix for the 
healing process. Fibroblasts and myofibroblasts interact and induce the 
formation of the ECM by collagen production. In the last phase, tissue 
remodeling, all processes slow down and cells undergo apoptosis. Collagen 
matrix is remodeled from type I to type III, and collagen fibrils form bundles 
giving rise to stronger tissues.   
The enhancement of angiogenesis is promising for the treatment of 
ischaemic diseases of the heart, peripheral vasculature, and chronic 
wounds
42
. HSGAGs are negatively charged, polydisperse molecules 
consisting of dimeric repeats of glucosamine and uronic acid residues with 
varying sulfation degress
43
. They are known to interact with proteins in 
physiological processes, including angiogenesis. Two types of HSGAGs are 
heparin and heparan sulfate. They are structurally similar but different in 
their sulfation degree. Heparin hs more sulfates compared to heparan
43
. Both 
molecules activate angiogenic growth factors. To learn more about the 
nature of the interaction between HSGAGs and proteins will allow the 
researchers develop successfully functioning mimicks for tissue engineering. 
We designed heparin-mimicking molecules to capture many potent signaling 
proteins, of which VEGF is an example, to promote angiogenesis. 
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CHAPTER 2 
 
EXPERIMENTAL SECTION  
 
2.1 General Methods 
Peptide amphiphiles were characterized by liquid chromatography-mass 
spectrometry (LC-MS). Mass spectrum was obtained with Agilent LC-QTOF-
MS equipped with Agilent Zorbax Extend-C18 2.1 x 50 mm column for 
negative molecules and Zorbax SB-C8 4.6 mm x 100 mm column for positive 
molecules. A gradient of (a) water (0.1% formic acid or 0.1% NH4OH) and (b) 
acetonitrile (0.1% formic acid or 0.1% NH4OH) was used. For purification of 
the molecules, reverse-phase HPLC system with Zorbax Extend-C18 21.2 x 150 
mm column for negative molecules and Zorbax SB-C8 21.2 x 150 mm column 
for positive molecules was employed. A gradient of (a) water (0.1% TFA or 
0.1% NH4OH) and (b) acetonitrile (0.1% TFA or 0.1% NH4OH) was used. 
 
2.2 Materials 
9-Fluorenylmethoxycarbonyl (Fmoc) and ter. Butoxycarbonyl (Boc) 
protected amino acids, Rink Amide MBHA resin and 2-(1H-Benzotriazol-1-yl)-
1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU) were purchased from 
14 
 
NovaBiochem and ABCR. Heparin was purchased from Sigma-Aldrich. 
Sheared Salmon Sperm DNA was purchased from Ambiogen. The other 
chemicals were purchased from Fisher, Merck, Alfa Aesar or Aldrich. All 
chemicals were used as provided.  
 
2.3 Synthesis of Peptides 
 Peptides were constructed on Rink Amide MBHA resin. Amino acid 
couplings were done with 2 equivalents of Fmoc protected amino acid, 1.95 
equivalents HBTU and 3 equivalents of N,N-Diisopropylethylamine (DIEA) for 
2 hours. Fmoc deprotections were performed with 20% Piperidine/DMF 
(Dimethylformamide) solution for 20 min. Cleavage of the peptides from the 
resin was carried out with a mixture of TFA:TIS:H2O in ratio of 95:2.5:2.5 for 2 
hours. Excess TFA was removed by rotary evaporation. The remaining viscous 
peptide solution was triturated with ice-cold ether and the resulting white 
product was dried under vacuum.  
 
2.4 Characterization of Peptide Amphiphiles 
Oscillatory Rheology 
 Oscillatory rheology measurements were performed with Anton Paar 
Physica RM301 Rheometer operating with a 25 mm parallel plate configuration 
at 25 °C. Each sample of 100 uL total volume with a final peptide concentration 
15 
 
of 1 wt % was carefully loaded on the center of the lower plate and waited for 
15 min before measuring. After equilibration, the upper plate was lowered to a 
gap distance of 0.5 mm. Storage moduli (G′) and loss moduli (G″) values were 
scanned from 100 rad/s to 0.1 rad/s of angular frequency, with a 0.5% shear 
strain. 
Circular Dichroism 
JASCO J815 CD spectrapolarimeter was used at room temperature. 2x10
-4
 
M samples were measured from 300 nm to 190 nm, data interval and data pitch 
being 0.1 nm, scanning speed being 100 nm/min, all measurements with three 
accumulations. D.I.T. was selected as 1 sec, band width as 1 nm, and the 
sensitivity was standard. 
FT-IR 
1 mg of 1 wt % lyophilized PA gel was grinded with 99 mg KBr until very 
fine powders were obtained. The finely ground mixtures were sandwiched 
between two stainless steel disks and hydraulic press was applied up to 7 atm. 
The FT-IR measurement was performed with Bruker Tenson 27 FT-IR 
spectrometer at the transmittance mode. The background spectrum was 
subtracted from the original spectrum. 
Zeta Potential and pH Titration 
Zeta potential measurements were performed with Malvern Nano-ZS 
zetasizer equipped with a titrator and pH meter for 0.06 wt % peptide 
amphiphile solutions. Smoluchovski approach was used to calculate the Zeta 
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Potential values. pH titration was done by adding 0.1 M HCl or NaOH to the 
appropriate solutions.  
Atomic Force Microscopy (AFM) 
The AFM samples were prepared by mixing 25 µL of PA solution of 0.025 
or 0.075 wt % final concentration with oppositely charged peptides, 
biomacromolecules or cations on a silicon wafer that had been cleaned by 
ethanol and dried at room temperature. DNA and heparin were mixed with PAs 
in a 1:3 ratio (0.025% DNA/Heparin with 0.075% PA). Asp-PA (0.025 wt %) 
and Lys-PA (0.025 wt %) were mixed in a 1:2 molar ratio. Asp-PA was mixed 
with calcium ions (CaCl2) in a 1:2 molar ratio. Sample solutions were dropped 
on the silicon wafer surface and mixed by pipetting up and down. After 30 
seconds, solvent on the wafer was removed by using dust-free paper towel and 
the rest was air-dried. Contact mode atomic force microscopy (AFM) was 
performed by using model MFP-30 from Asylum Research. All images were 
taken with 0.5 Hz scan rate. Tips with resonance frequency of 13 kHz and 
spring constant of 0.2 N/m were used in all experiments.  
Scanning Electron Microscopy (SEM) 
100 μl of PA gels with a final concentration of 1 wt% were placed on a 
metal mesh, dried at critical point (1072 Psi, 31 ºC) with Tousimis Autosamdri-
815 B, Series C critical point dryer and coated with 6 nm Au-Pd. SEM imaging 
was performed with FEI Quanta 200 FEG, using the ETD detector at high 
vacuum mode with 30 keV beam energy. 
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Transmission Electron Microscopy (TEM) 
TEM was performed with FEI Tecnai G2 F30. Diluted samples were placed 
on a Lacey mesh ultrathin carbon coated copper grid. 2 wt % uranyl acetate 
solution or phosphotungstic acid solutions were used for positive and negative 
staining, respectively. The grid was put onto 1 wt % PA gel upside down for 1 
min. Then, the grid was washed to remove excess coating and was put over the 
staining solution for 15 min.  After the staining, the grids were dried in the fume 
hood at room temperature overnight. 
Isothermal Titration Calorimetry (ITC) 
Isothermal titration calorimetry was performed with MicroCal Auto-ITC200 
device, having 4.4x10
-8
 M of VEGF in the syringe and 2.2x10
-9
 M of heparin or 
sample in the cell, both in water. Raw data of heat released vs. molar ratio were 
obtained, and were integrated after background correction and fit to a  curve for 
a single type of binding site to obtain a binding constant. 
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CHAPTER 3 
 
RESULTS AND DISCUSSIONS 
 
3.1. Electrostatic Effects on Self-Assembly 
In order to better understand the self-assembly mechanism, three peptide 
amphiphiles (PA) were designed and synthesized by solid phase peptide 
synthesis method and mixed with various molecules of opposite charge to 
explore the effect of electrostatic interactions on the nanofiber formation 
(Figure 1). The lauric acid adds hydrophobic character to peptide 
amphiphiles, contributing to the hydrophobic driving force of the self-
assembly. The peptide part consists of four nonpolar amino acid residues, 
forming the β-sheet module; and a charged amino acid for solubility and 
charge control. Lys-PA (Lauryl-VVAGK-Am) was designed to have a 
lysine residue at its N-terminus; as it was positively charged at acidic 
conditions, it formed gels upon increasing the pH and mixing with both 
negatively charged macromolecules (e.g. heparin and DNA), and by addition 
og Asp-PA (Lauryl-VVAGD), a negatively charged PA at neutral 
conditions, and by making the pH basic. His-PA (Lauryl-VVAGH-Am) was 
designed with a histidine residue making it soluble in acidic solutions and 
gel above pH 6.5. Asp-PA (Lauryl-VVAGD) is a negatively charged PA at  
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Figure 2. Chemical representation of PAs. 
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basic conditions and formed gels in the presence of calcium ions and 
positively charged molecules at neutral pH, as well as at low pH conditions. 
The mass spectrometry and the HPLC chromatgorams can be seen in Figures 
3-8. The self-assembly of the PA molecules was studied by zeta potential 
measurements to determine the charges over peptides (Figure 9) and titration 
curves to determine the pKa transitions of ionizable groups at self-assembly 
conditions (Figure 10). The ionizable groups for Lys-PA are amine groups, 
the ε-amine of lysine, reported to have a pKa of 10.5. The pKa from the 
titration curve can be inferred as pH 6.0 - 6.5; it belongs to the ε-amine of 
lysine in the peptide backbone and is shifted downwards. The titration 
curves for L-Lysine and poly-L-Lysine are shown to be horizontal at pH 
values above 8
44
. There is an ionizable imidazole side chain on the His-PA 
and its neutralization was observed around pH 6.5 (Figure 10b). The Asp-
PA has two carboxylic acid groups at the C-terminal and the side chain. The 
pKa transition values of aspartic acid are 3.9 and 9.8, for the C-terminal and 
side chain respectively; the value of one of the carboxyl groups is shifted as 
can be seen from the graphic. In the literature, such shifts have been seen in 
other peptide amphiphiles as well
45-46
. The shifts can be explained by 
aggregation of the molecules, which changes the apparent pKa values of the 
acid and amine groups
45
. The protonation/deprotonation of ionizable groups 
must have occurred slowly, as can be understood from the curves with 
transitions over wide ranges. The Lys-PA and His-PA are positively 
charged charged at pH lower than 5, whereas Asp-PA is negatively charged  
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Figure 3. Mass spectrometry of the Lys-PA. 
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Figure 4. RP-HPLC chromatogram of the Lys-PA. 
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Figure 5. Mass spectrometry of the His-PA. 
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Figure 6. RP-HPLC chromatogram of the His-PA. 
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Figure 7. Mass spectrometry of the Asp-PA. 
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Figure 8. RP-HPLC chromatogram of the Asp-PA. 
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at pH over 5. Zeta potential measurement demonstrated the charge of the 
solutions, as well as their stability. High positive or negative zeta potential 
makes the molecules repel each other so they don’t coagulate. If the zeta 
potential is low, then there will be no force to prevent the flocculation of 
molecules. Values above +30 mV or below -30 mV are considered to 
represent sufficient repulsion between molecules to ensure physical stability. 
The Lys-PA solution becomes more negative with increasing pH by adding 
alkali solution. It doesn’t start to coagulate until a pH close to 10 is reached 
as the charges are not fully neutralized. The Asp-PA solution is unstable 
below pH 4, as there are not sufficient negative charges present. The His-PA 
solution reveals a different profile; it normally gelates around pH 6.5, and 
the system starts to lose stability after pH 7; however, it is not until pH 9 that 
its zeta potential becomes lower than 30 mV. These results are consistent 
with the gelation behaviors of the PA molecules. 
The self-assembly of the PA molecules was characterized by various 
microscopy imaging techniques.  The charged residues of PAs interact with 
oppositely charged ions and molecules, and the PAs assemble into 
nanofibers with diameters about 8 nm and lengths up to a few microns as 
revealed by TEM and AFM. For Lys-PA samples, the charge screening of 
the amine group by hydronium ions (Figure 12b and 12c), heparin (Figure 
13b and 13c), DNA (Figure 14b and 14c) or the aspartate moiety of the Asp-
PA (Figure 15b and 15c) resulted in aggregation of the molecules, and 
formation of nanofibers. The screening of the charges on the carboxyl 
groups of the Asp-PA by calcium ions (Figure 11b and 11c) or hydronium 
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ions (Figure 16b and 16c) minimized the electrostatic repulsion among the 
headgroups of the peptides, and made them come together and form fibers as 
well. The imidazole side-chain of histidine on the His-PA carries a positive 
charge at low pH but is neutralized at neutral and high pH and self-assemble 
into fibrillar structures (Figure 17). In some TEM images (Figure 17), plaque 
structures below fibers were observed. The samples for imaging were 
prepared by dehydrating and drying in air, this might have resulted in the 
fusion of nanofibers
47
 and as a result, in the formation of sheet-like 
structures.  
AFM imaging revealed the formation of PA nanofibers depending on pH 
change (pH 2 for Asp-PA, pH 7 for His-PA and pH 10 for Lys-PA) or 
mixing with charged macromolecules (DNA, heparin with Lys-PA) and 
cations (Ca
2+
 with Asp-PA). Asp-PA with Ca
2⁺ formed longer fibrils 
(Figure 11) compared to other peptide amphiphiles (Figures 12-17). Calcium 
presumably acts as a connector between the carboxyl groups of the aspartate 
residues, as proposed in another study.
48
 This might aid in the self-assembly 
process to produce stronger bonds and hence, a longer fibril (Figure 11b). 
Three-dimensional network of the nanofibers were observed by SEM 
(Figures 11a-17a).   
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Figure 9. pH dependent Zeta Potential measurements of a) Lys-PA titrated with 0.1 M 
NaOH, b) His-PA titrated with 0.1 M NaOH, and c) Asp-PA titrated with 0.1 M HCl. 
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Figure 10. pH titration curves of PAs. a) Lys-PA titrated with 0.1 M NaOH, b) His-PA 
titrated with 0.1 M NaOH, c) Asp-PA titrated with 0.1 M HCl.
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Figure 11. SEM, TEM and AFM images of the Asp-PA with Ca
2+
.
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Figure 12. SEM, TEM and AFM images of the Lys-PA at pH 10. 
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Figure 13. SEM, TEM and AFM images of the Lys-PA with heparin. 
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Figure 14. SEM, TEM and AFM images of the Lys-PA with DNA. 
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Figure 15. SEM, TEM and AFM images of the Lys-PA with Asp-PA. 
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Figure 16. SEM, TEM and AFM images of the Asp-PA at pH 2. 
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Figure 17. SEM, TEM and AFM images of the His-PA at pH 7. 
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FT-IR was used to analyze characteristic bands for hydrogen bonding 
belonging to peptides (Figure 18). The amide A band around 3300-3500 cm
-
1
and amide B band around 3100 cm
-1
are due to a Fermi resonance of the NH 
stretching vibration and the first overtone of the amide II. Amide I band, 
observed between 1600-1700 cm
-1
, is associated with the carbonyl stretching 
vibrations of the peptide backbone. Amide II results from the C-N stretching 
vibrations and NH deformation vibrations. Amide II band might have changing 
frequencies depending on the peptide conformation. Amide III vibration is 
conformationally highly sensitive. Amide III and Amide IV are often not used to 
gather information as they are very complex bands dependent on many factors. 
Amide V, amide VI and amide VIII modes are out-of-plane bending vibrations. 
The peaks around 1650 cm
-1
and 1693 cm
-1
can be attributed to parallel and 
antiparallel β -sheets, respectively. There are peaks around 1730 cm-1in Asp-PA 
at pH 2, Asp-PA with Ca
2⁺, and Lys-PA with Asp-PA with the strongest peak 
being observed at pH 2 sample, the carbonyl stretching vibration of aspartate 
side chain is known to generate a peak around those values
49
. Lysine side chain 
gives weak bands in infrared in neutralized state, making the bands difficult to 
assign. At 1228 cm
-1
, the asymmetric stretching of sulfate belonging to heparin 
is observed. No α-helical structures were observed in the FT-IR.  
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Figure 18. FT-IR spectra of lyophilized PA gels. 
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Figure 19. CD spectra of PA solutions. 
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To understand the secondary structures and conformations of the PAs, 
circular dichroism (CD) spectroscopy was employed (Figure 19). When the 
structure of a molecule is chiral, there is a difference in the absorbance of right-
handed polarized light versus left-handed polarized light. CD measures these 
absorbance differences, where the amide group forming the peptide backbone in 
regular environment acts as the chromophore in the far-UV region. The β-sheets 
display negative minimum at 218 nm and positive ellipticity at 195 nm.
50
 The 
Lys-PA at pH 7 with DNA and heparin contains predominantly β-sheet 
structure. At pH 10, Lys-PA displays a predominant β-sheet as well; similar to 
those of Asp-PA at pH 2 and Asp-PA/Ca
2+
. The His-PA at pH 7 has n→π* 
transition around 220 nm, indicating the presence of the β-sheet structure. 
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Figure 20. Oscillatory rheology measurements of the PA gels. 
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Mixing the PAs with oppositely charged ions and molecules, gel formation 
could be seen by the naked eye. The gel formation was characterized by 
oscillatory rheology measurements (Figure 20). The gelation point is the 
defining characteristic between a gel and a viscous liquid; at that point the 
storage modulus (G′) is higher than the loss modulus (G′). The storage moduli of 
all samples were significantly higher than their loss moduli, proving the gel 
formation. Three-dimensional scaffolds for tissue engineering should have 
adequate mechanical strength, which has been shown to affect the growth, 
differentiation and migration of cells
51
. Tissue elastic moduli start from 0.1 kPa 
for soft tissues and can reach up to GPas for hard tissues
52. The Young’s moduli 
of the PA gels are within the range of moduli of elasticity of living tissues. 
 
3.2. Self-assembling PA molecules in angiogenesis  
We designed a heparin-mimicking peptide amphiphile (Sulfo-PA: C12-
VVAGEK-pbenzosulfonate) bearing a sulfate group to promote angiogenesis in 
the body. A heparin-mimicking structure can capture many signaling proteins 
taking part in angiogenesis. Two dumb peptides (Lys-PA and Asp-PA) 
containing no sulfate groups were used for see the effects of the sulfate group on 
binding. (Figure 21) Rheology was done to assess the mechanical strength of the 
structures. CD measurement showed us the secondary structures, and ITC 
measurements were done to determine whether the PA binds to VEGF 
specifically, and how strong the binding is. Mass spectrometry and RP-HPLC 
chromatograms can be observed in Figures 22-23. 
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Figure 21. The chemical representation of PAs for the angiogenesis study. 
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Figure 22. Mass spectrometry of the Sulfo-PA. 
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Figure 23. RP-HPLC chromatogram of the Sulfo-PA. 
 
 
47 
 
 
Figure 24. CD spectra of PA solutions. 
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Figure 25. Oscillatory rheology measurements of the PA gels. 
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Circular dichroism (CD) spectroscopy was employed to observe the 
secondary structures of peptide amphiphiles (Figure 24). All molecules exhibit a 
n→π* transition around 220 nm, so they have β-sheet structures. 
PAs formed gels upon mixing with oppositely charged ions and molecules. 
The gel formation was characterized by oscillatory rheology measurements 
(Figure 25). The storage moduli of all samples were significantly higher than 
their loss moduli, indicating gel formation.  
To verify the PA-VEGF binding affinity, isothermal titration calorimetry 
(ITC) was employed. Increments of VEGF in solution were titrated into heparin 
or PA in solution, and the released heat due to binding was measured. The data 
was integrated and fitted to obtain the association constants; then, plotted 
against the molar ratio of the molecules (Figures 26-31). The association 
constant indicates how strong the binding is, and can be compared to the values 
obtained from heparin-VEGF binding and the binding of other synthetic VEGF-
binding peptides to VEGF. Comparing the results, all molecules seem to have 
similar association constants, which are close to the heparin-VEGF association 
constant. The strong binding of PAs not containing any sulfate group might be 
explained by the self-assembly of PA monomers at van der Waals density on the 
aggregates’ surfaces53.  ITC can also used to characterize the binding event, by 
the values obtained like the Gibbs free energy change (ΔG), the enthalpy change 
(ΔH) and entropy change of the interaction (ΔS)54. As the enthalpy change is 
higher than the entropy change, we might conclude electrostatic interactions 
overcome the hydrophobic ones. 
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Figure 26. Isothermal titration calorimetry measuring the binding of VEGF to 
heparin. 
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Figure 27. Isothermal titration calorimetry measuring the binding of VEGF to 
Asp-PA. 
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Figure 28. Isothermal titration calorimetry measuring the binding of 
VEGF to Asp-Pa with Ca
2+
. 
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Figure 29. Isothermal titration calorimetry measuring the binding of 
VEGF to Lys-PA. 
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Figure 30. Isothermal titration calorimetry measuring the binding of 
VEGF to Sulfo-PA. 
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Figure 31. Isothermal titration calorimetry measuring the binding of 
VEGF to Asp-PA with Lys-PA. 
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CHAPTER 4 
 
CONCLUSION 
The peptide amphiphiles molecules were designed and synthesized to study 
the effects of charge screening in their self-assembly by various characterization 
methods. Peptide amphiphiles self-assemble into nanofibers, which provide 
useful three-dimensional scaffolds in their gelled form for tissue engineering. 
Rheology measurements show that the formed gels have enough strength to 
support some kind of soft tissue. Secondary structures of the peptides were 
investigated as well. By zeta potential measurements, the peptides have been 
shown to aggregate upon neutralization of the charged residues by mixing with 
ions or oppositely charged molecules; and the molecules were imaged with 
TEM, SEM and AFM to determine their diameter, length, density and other 
properties.  
Electrostatic control of the molecules is very important in the development 
of minimally invasive injections with maximal functionality, where the PA 
molecules can be designed to have biologically active sequences and to self-
assemble into nanofibers in the body upon encountering ions and molecules of 
opposite charge, or can be combined with bioactive molecules like DNA, 
glycosaminoglycans, and growth factors for self-assembling into biodegradable 
networks. Such systems will change the future of medicine by allowing to inject 
the PAs into the tissue and to induce self-assembly of functional peptide 
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sequences in situ to form versatile gelled networks which can encapsulate 
molecules and cells for various medical applications.  
Peptide amphiphiles are promising candidates for mimicking various 
processes taking place in the body, such as angiogenesis. Vascular endothelial 
growth factor promotes angiogenesis by binding heparin like sequences. We 
designed heparin-mimicks which contain sulfate groups in their structure. This 
approach allows us to use peptides to induce angiogenesis by capturing the 
proteins to sites where they are needed, instead of applying them from outside, 
which might be very expensive. in vitro and in vivo experiments of angiogenesis 
and wound healing applications are continuing. 
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